Chronic arthritis in childhood

Textbook of Pediatric Rheumatology

Volumn , Issue , 2011, Pages 211-235

  Petty, Ross E ^c   Cassidy, James T ^a,b  

^a University of Missouri   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882485604     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-6581-4.10013-5     Document Type: Chapter

References (510)

1. Brewer E.J., Bass J.C., Cassidy J.T. Criteria for the classification of juvenile rheumatoid arthritis. Bull. Rheum. Dis 1972, 23:712-719.
2. European League Against Rheumatism EULAR Bulletin no. 4: nomenclature and classification of arthritis in children 1977, National Zeitung AG, Basel.
3. Petty R.E., Southwood T.R., Manners P., et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis 2001, second revision, Edmonton, J. Rheumatol. 31 (2004) 390-392.
4. Still G.F. On a form of chronic joint disease in children. Med. Chirurg. Trans 1897, 80:47.
5. Oen K. Comparative epidemiology of the rheumatic diseases in children. Curr. Opin. Rheumatol 2000, 12:410-414.
6. Andersson G.B. Juvenile arthritis-who gets it, where and when? A review of current data on incidence and prevalence. Clin. Exp. Rheumatol 1999, 17:367-374.
7. Mielants H., Veys E.M., Maertens M., et al. Prevalence of inflammatory rheumatic diseases in an adolescent urban student population, age 12 to 18, in Belgium. Clin. Exp. Rheumatol 1993, 11:563-567.
8. Manners P.J., Diepeveen D.A. Prevalence of juvenile chronic arthritis in a population of 12-year-old children in urban Australia. Pediatrics 1996, 98:84-90.
9. Malleson P.N., Fung M.Y., Rosenberg A.M. The incidence of pediatric rheumatic diseases: results from the Canadian Pediatric Rheumatology Association Disease Registry. J. Rheumatol 1996, 23:1981-1987.
10. Symmons D.P., Jones M., Osborne J., et al. Pediatric rheumatology in the United Kingdom: data from the British Pediatric Rheumatology Group National Diagnostic Register. J. Rheumatol 1996, 23:1975-1980.
11. Sauernmann R.K., Rose J.B., Tyrell P., et al. Epidemiology of juvenile idiopathic arthritis in a multiethnic cohort. Arthritis Rheum 2007, 56:1974-1984.
12. De Benedetti F., Ravelli A., Martini A. Cytokines in juvenile rheumatoid arthritis. Curr. Opin. Rheumatol 1997, 9:428-433.
13. Woo P. Cytokines and juvenile idiopathic arthritis. Curr. Rheumatol. Rep 2002, 4:452-457.
14. Foell D., Roth J. Proinflammatory S100 proteins in arthritis and autoimmune disease. Arthritis Rheum 2004, 50:3762-3771.
15. Pascual V., Allantaz F., Arce E., et al. Role of interleukin 1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis, and clinical response to IL-1 blockade. J. Exp. Med 2005, 201:1479-1486.
16. Avcin T., Cimaz R., Falcini F., et al. Prevalence and clinical significance of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis. Ann. Rheum. Dis 2002, 61:608-611.
17. Muzaffer M.A., Dayer J.M., Feldman B.M., et al. Differences in the profiles of circulating levels of soluble tumor necrosis factor receptors and interleukin 1 receptor antagonist reflect the heterogeneity of the subgroups of juvenile rheumatoid arthritis. J. Rheumatol 2002, 29:1071-1078.
18. Prakken B., Kuis W., Van Eden W., et al. Heat shock proteins in juvenile idiopathic arthritis: keys for understanding remitting arthritis and candidate antigens for immune therapy. Curr. Rheumatol. Rep 2002, 4:466-473.
19. Albani S. Infection and molecular mimicry in autoimmune diseases of childhood. Clin. Exp. Rheumatol 1994, 12(Suppl. 10):S35-S41.
20. Phelan J.D., Thompson S.D., Glass D.N. Susceptibility to JRA/JIA: complementing general autoimmune and arthritis traits. Genes Immun 2006, 7:1-10.
21. Murray K.J., Moroldo M.B., Donnelly P., et al. Age-specific effects of juvenile rheumatoid arthritis-associated HLA alleles. Arthritis Rheum 1999, 42:1843-1853.
22. Thomson W., Barrett J.H., Donn R., et al. Juvenile idiopathic arthritis classified by the ILAR criteria: HLA associations in UK patients. Rheumatology (Oxf) 2002, 41:1183-1189.
23. Hinks A., Barton A., John S., et al. Association between PTPN22 and rheumatoid arthritis and juvenile idiopathic arthritis in a UK population. Arthritis Rheum 2005, 52:1694-1699.
24. Hinks A., Ke X., Barton A., et al. Association of the IL2RA CD25 gene with juvenile idiopathic arthritis. Arthritis Rheum 2009, 60:251-257.
25. Anthony K.K., Schanberg L.E. Assessment and management of pain syndromes and arthritis pain in children and adolescents. Rheum. Dis. Clin. North Am 2007, 33:625-660.
26. Malleson P.N., Oen K., Cabral D.A., et al. Predictors of pain in children with established juvenile rheumatoid arthritis. Arthritis Rheum 2004, 51:222-227.
27. Foster H.E., Kay L.J., Friswell M., et al. Musculoskeletal screening examination (pGALS) for school age children based on the adult GALS screen. Arthritis Rheum 2006, 55:709-716.
28. Lelieveld O.T., Armbrust W., Van Leeuwen M.A., et al. Physical activity in adolescents with juvenile idiopathic arthritis. Arthritis Rheum 2008, 59:1379-1384.
29. Kruithof E., Van den Bossche V., De Ryke L., et al. Distinct synovial histopathologic characteristics of juvenile onset spondyloarthritis and other forms of juvenile idiopathic arthritis. Arthritis Rheum 2006, 54:2594-2604.
30. Cabral D.A., Petty R.E., Fung M., et al. Persistent antinuclear antibodies in children without identifiable inflammatory rheumatic or autoimmune disease. Pediatrics 1992, 89:441-444.
31. Ilowite N.T., Samuel P., Beseler L., et al. Dyslipoproteinemia in juvenile rheumatoid arthritis. J. Pediatr 1989, 114:823-826.
32. Ilowite L.B., Cabral D.A. Transition of the adolescent patient with rheumatic disease: issues to consider. Ped. Clin. North Am 2005, 52:641-652.
33. Giannini E.H., Ruperto N., Ravelli A., et al. Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum 1997, 40:1202-1209.
34. Brunner H.I., Lovell D.J., Finck B.K., et al. Preliminary definition of disease flare in juvenile rheumatoid arthritis. J. Rheumatol 2002, 29:1058-1064.
35. G. Kuchta, I. Davidson, Occupational and Physical Therapy for Children with Rheumatic Diseases, Radcliffe, Oxford (2009).
36. Carl H.-D., Schraml A., Swoboda B., et al. Synovectomy of the hip in patients with juvenile rheumatoid arthritis. J. Bone Joint Surg 2007, 89:1986-1992.
37. Dell'Era L., Facchini R., Corona F. Knee synovectomy in children with juvenile idiopathic arthritis. J. Ped. Ortho. B 2008, 17:128-130.
38. Dempster H., Porepa M., Young N., et al. The clinical meaning of functional outcome scores in children with juvenile arthritis. Arthritis Rheum 2001, 44:1768-1774.
39. Fantini F., Gerloni V., Gattinara M., et al. Remission in juvenile chronic arthritis: a cohort study of 683 consecutive cases with a mean 10 year followup. J. Rheumatol 2003, 30:579-584.
40. Oen K., Malleson P.N., Cabral D.A., et al. Early predictors of longterm outcome in patients with juvenile rheumatoid arthritis: subset-specific correlations. J. Rheumatol 2003, 30:585-593.
41. Guillaume S., Prieur A.M., Coste J., et al. Long-term outcome and prognosis in oligoarticular-onset juvenile idiopathic arthritis. Arthritis Rheum 2000, 43:1858-1865.
42. Spiegel L.R., Schneider R., Lang B.A., et al. Early predictors of poor functional outcome in systemic-onset juvenile rheumatoid arthritis: a multicenter cohort study. Arthritis Rheum 2000, 43:2402-2409.
43. Packham J.C., Hall M.A. Long-term follow-up of 246 adults with juvenile idiopathic arthritis: functional outcome. Rheumatology (Oxf) 2002, 41:1428-1435.
44. Minden K., Niewerth M., Listing J., et al. Long-term outcome in patients with juvenile idiopathic arthritis. Arthritis Rheum 2002, 46:2392-2401.
45. Oen K., Malleson P.N., Cabral D.A., et al. Disease course and outcome of juvenile rheumatoid arthritis in a multicenter cohort. J. Rheumatol 2002, 29:1989-1999.
46. Oen K., Reed M., Malleson P.N., et al. Radiologic outcome and its relationship to functional disability in juvenile rheumatoid arthritis. J. Rheumatol 2003, 30:832-840.
47. Thomas E., Symmons D.P., Brewster D.H., et al. National study of cause-specific mortality in rheumatoid arthritis, juvenile chronic arthritis, and other rheumatic conditions: a 20 year followup study. J. Rheumatol 2003, 30:958-965.
48. Minden K., Niewerth M., Listing J., et al. Burden and cost of illness in children with juvenile idiopathic arthritis. Ann. Rheum. Dis 2004, 63:836-842.
49. Bernatsky S., Duffy C., Malleson P., et al. Economic impact of juvenile idiopathic arthritis. Arthritis Care Res 2007, 57:44-48.
50. Thornton J., Lunt M., Ashcroft D.M., et al. Costing juvenile idiopathic arthritis: examining patient based costs during the first year after diagnosis. Rheumatology (Oxf.) 2008, 47:985-990.
51. Brewer E.J., Bass J.C., Cassidy J.T. Criteria for the classification of juvenile rheumatoid arthritis. Bull. Rheum. Dis 1972, 23:712-719.
52. European League Against Rheumatism EULAR Bulletin no. 4: nomenclature and classification of arthritis in children 1977, National Zeitung AG, Basel.
53. Fink C.W. Proposal for the development of classification criteria for idiopathic arthritides of childhood. J. Rheumatol 1995, 22:1566-1569.
54. Brewer E.J., Bass J., Baum J., et al. Current proposed revision of JRA Criteria. JRA Criteria Subcommittee of the Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Section of the Arthritis Foundation. Arthritis Rheum 1977, 20:195-199.
55. Cassidy J.T., Levinson J.E., Bass J.C., et al. A study of classification criteria for a diagnosis of juvenile rheumatoid arthritis,. Arthritis Rheum 1986, 29:274-281.
56. Cassidy J.T., Levinson J.E., Brewer E.J. The development of classification criteria for children with juvenile rheumatoid arthritis,. Bull. Rheum. Dis 1989, 38:1-7.
57. Petty R.E., Southwood T.R., Baum J., et al. Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban. J. Rheumatol 1997, 25:1991-1994. 1998.
58. Petty R.E. Growing pains: the ILAR classification of juvenile idiopathic arthritis. J. Rheumatol 2001, 28:927-928.
59. Petty R.E., Southwood T.R., Manners P., et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision Edmonton 2001. J. Rheumatol. 31 2004, 390-392.
60. Fantini F. Classification of chronic arthritides of childhood (juvenile idiopathic arthritis): criticisms and suggestions to improve the efficacy of the Santiago-Durban criteria. J. Rheumatol 2001, 28:456-459.
61. Ramsey S.E., Bolaria R.K., Cabral D.A., et al. Comparison of criteria for the classification of childhood arthritis. J. Rheumatol 2000, 27:1283-1286.
62. Foeldvari I., Bidde M. Validation of the proposed ILAR classification criteria for juvenile idiopathic arthritis. International League of Associations for Rheumatology. J. Rheumatol 2000, 27:1069-1072.
63. Berntson L., Fasth A., Andersson-Gare B., et al. Construct validity of ILAR and EULAR criteria in juvenile idiopathic arthritis: a population based incidence study from the Nordic countries. International League of Associations for Rheumatology. European League Against Rheumatism. J. Rheumatol 2001, 28:2737-2743.
64. Merino R., De Inocencio J., Garcia-Consuegra J. Evaluation of ILAR classification criteria for juvenile idiopathic arthritis in Spanish children. J. Rheumatol 2001, 28:2731-2736.
65. Krumrey-Langkammerer M., Hafner R. Evaluation of the ILAR criteria for juvenile idiopathic arthritis. J. Rheumatol 2001, 28:2544-2547.
66. Hofer M.F., Mouy R., Prieur A.M. Juvenile idiopathic arthritides evaluated prospectively in a single center according to the Durban criteria. J. Rheumatol 2001, 28:1083-1090.
67. Berntson L., Fasth A., Andersson-Gare B., et al. The influence of heredity for psoriasis on the ILAR classification of juvenile idiopathic arthritis,. J. Rheumatol 2002, 29:2454-2458.
68. Flato B., Smerdel A., Johnston V., et al. The influence of patient characteristics, disease variables, and HLA alleles on the development of radiographically evident sacroiliitis in juvenile idiopathic arthritis,. Arthritis Rheum 2002, 46:986-994.
69. Martini A. Are the number of joints involved or the presence of psoriasis still useful tools to identify homogeneous disease entities in juvenile idiopathic arthritis?. J. Rheumatol 2003, 30:1900-1903.
70. Tsitsami E., Bozzola E., Magni-Manzoni S., et al. Positive family history of psoriasis does not affect the clinical expression and course of juvenile idiopathic arthritis patients with oligoarthritis. Arthritis Rheum 2003, 49:488-493.
71. Manners P., Lesslie J., Speldewinde D., et al. Classification of juvenile idiopathic arthritis: should family history be included in the criteria?. J. Rheumatol 2003, 30:1857-1863.
72. Merino R., de Inocencfio J., Garcia-Consuegra J. Evaluation of revised International League of Associations for Rheumatology classification criteria for juvenile idiopathic arthritis in Spanish children (Edmonton 2001). J. Rheumatol 2005, 32:559-561.
73. Stoll M.L., Lio P., Sundel R.P. Nigrovic PA: Comparison of Vancouver and International League of Associations for Rheumatology classification criteria for juvenile psoriatic arthritis. Arthritis Rheum 2008, 59:51-58.
74. Behrens E.M., Breukelman T., Cron R.Q. Juvenile idiopathic arthritis classification criteria: Loopholes and diagnosis software. J. Rheumatol 2007, 34:234.
75. Stabile A., Avalone L., Compagnone A., et al. Focus on juvenile idiopathic arthritis according to the 2001 Edmonton revised classification from the Internal League of Associations for Rheumatology: an Italian experience, Eur. Rev. Med. Pharmacol. Sci 2007, 10:229-234.
76. N. Saxena, R. Misra, A. Aggarwal, Is the enthesittis-related arthritis subtype of juvenile idiopathic arthritis a form of chronic reactive arthritis? Rheumatology (Oxford) 45 (2006) 1129-1132.
77. Cassidy J.T. What's in a name? Nomenclature of juvenile arthritis, a North American view, J. Rheumatol. (suppl 1993, 40):4-8.
78. Southwood T.R., Woo P. Childhood arthritis: the name game. Br. J. Rheumatol 1993, 32:421-423.
79. Holt P.J. The classification of juvenile chronic arthritis,. Clin. Exp. Rheumatol 1990, 8:331-333.
80. Huppertz H.I. Viewpoint: time for change in pediatric rheumatology. Rheumatol. Int 1993, 13:37-38.
81. Cornil M.V. Memoire sur les coincidences pathologiques du rhumatisme articulaire chronique. C. R. Mem. Soc. Biol. (Paris.) 1864, 4:3.
82. Diamant-Berger M.S. Du rhumatisme noueux (polyarthrite deformante) chez les enfants 1891, Lecrosnier et Babe, Paris.
83. Still G.F. On a form of chronic joint disease in children. Med. Chirurg. Trans 1897, 80:47.
84. Hirschsprung H. Multipel, kronisk, infektios Ledsygdom I. Barnealderen 1901, Hospitalstid 421.
85. Atkinson F.R.B. Still's disease. Br. J. Child Dis 1939, 36:100.
86. Edstrom G. Rheumatoid arthritis in children. Acta. Paediatr. Scand 1947, 34:334.
87. Bille B.S.V. Kronisk Polyartrit hos barn och dess Guldbehandling. Nord. Med 1948, 37:307.
88. Short C.L., Bauer W., Reynolds W.E. Rheumatoid arthritis 1957, Harvard University Press, Cambridge.
89. Colver T. The prognosis in rheumatoid arthritis in childhood,. Arch. Dis. Child 1937, 12:253.
90. Holzmuller G. Beitrag zur Frage der Pathogenese und Therapie der primar-chronischen Gelenkerkrankungen im Kindesalter. Ztschr. F. Rheumaforsch 1942, 5:57.
91. Coss J.A., Boots R.H. Juvenile rheumatoid arthritis. J. Pediatr 1946, 29:143.
92. Pickard N.S. Rheumatoid arthritis in children: a clinical study. Arch. Intern. Med 1947, 80:771.
93. Lockie L.M., Norcross B.M. Juvenile rheumatoid arthritis. Pediatrics 1948, 2:694.
94. Wissler H. Der Rheumatismus im Kindesalter. Teil 2: Die chronische Polyartritis des Kindes. Der. Rheumatismus. Bd 1942, 24. Dresden und LeipzigSteinkopff.
95. Françon F. Conferences cliniques de rhumatologie pratique 1946, Paris.
96. Dawson M.H. Rheumatoid arthritis in children (Still's disease). Nelson Loose-leaf Medicine 1946, T Nelson & Sons, New York. W.W. Palmer (Ed.).
97. Stoeber E. Juvenile chronic polyarthritis and Still's syndrome. Doc. Geigy 1977, 1.
98. Oen K.G., Cheang M. Epidemiology of chronic arthritis in childhood. Semin. Arthritis Rheum 1996, 26:575-591.
99. Oen K. Comparative epidemiology of the rheumatic diseases in children. Curr. Opin. Rheumatol 2000, 12:410-414.
100. Andersson G.B. Juvenile arthritis-who gets it, where and when? A review of current data on incidence and prevalence,. Clin. Exp. Rheumatol 1999, 17:367-374.
101. Nielsen H.E., Dorup J., Herlin T., et al. Epidemiology of juvenile chronic arthritis: risk dependent on sibship, parental income, and housing. J. Rheumatol 1999, 26:1600-1605.
102. Mielants H., Veys E.M., Maertens M., et al. Prevalence of inflammatory rheumatic diseases in an adolescent urban student population, age 12 to 18, in Belgium. Clin. Exp. Rheumatol 1993, 11:563-567.
103. Manners P.J., Diepeveen D.A. Prevalence of juvenile chronic arthritis in a population of 12-year-old children in urban Australia. Pediatrics 1996, 98:84-90.
104. Laaksonen A.L. A prognostic study of juvenile rheumatoid arthritis: analysis of 544 cases. Acta. Paediatr. Scand 1966, 1-163.
105. Oen K., Fast M., Postl B. Epidemiology of juvenile rheumatoid arthritis in Manitoba, Canada, 1975-1992: cycles in incidence. J. Rheumatol 1995, 22:745-750.
106. Bywaters E.G. Diagnostic criteria for Still's disease (juvenile RA). Excerpta Medica 1968, Population studies of the rheumatic diseases, Amsterdam. P.H. Bennett, P.H.N. Wood (Eds.).
107. Sullivan D.B., Cassidy J.T., Petty R.E. Pathogenic implications of age of onset in juvenile rheumatoid arthritis. Arthritis Rheum 1975, 18:251-255.
108. Towner S.R., Michet C.J., O'Fallon W.M., et al. The epidemiology of juvenile arthritis in Rochester, Minnesota, 1960-1979,. Arthritis Rheum 1983, 26:1208-1213.
109. Gewanter H.L., Roghmann K.J., Baum J. The prevalence of juvenile arthritis,. Arthritis Rheum 1983, 26:599-603.
110. Kunnamo I., Kallio P., Pelkonen P. Incidence of arthritis in urban Finnish children. a prospective study. Arthritis Rheum 1986, 29:1232-1238.
111. Prieur A.M., Le Gall E., Karman F., et al. Epidemiologic survey of juvenile chronic arthritis in France. Comparison of data obtained from two different regions. Clin. Exp. Rheumatol 1987, 5:217-223.
112. Rosenberg A.M. Analysis of a pediatric rheumatology clinic population. J. Rheumatol 1990, 17:827-830.
113. Gerhardt C.A., Vannatta K., McKellop J.M., et al. Brief report: child-rearing practices of caregivers with and without a child with juvenile rheumatoid arthritis: perspectives of caregivers and professionals. J. Pediatr. Psychol 2003, 28:275-279.
114. Denardo B.A., Tucker L.B., Miller L.C., et al. Demography of a regional pediatric rheumatology patient population: Affiliated Children's Arthritis Centers of New England. J. Rheumatol 1994, 21:1553-1561.
115. Malleson P.N., Fung M.Y., Rosenberg A.M. The incidence of pediatric rheumatic diseases: results from the Canadian Pediatric Rheumatology Association Disease Registry,. J. Rheumatol 1996, 23:1981-1987.
116. Kaipiainen-Seppanen O., Savolainen A. Incidence of chronic juvenile rheumatic diseases in Finland during 1980-1990. Clin. Exp. Rheumatol 1996, 14:441-444.
117. Symmons D.P., Jones M., Osborne J., et al. Pediatric rheumatology in the United Kingdom: data from the British Pediatric Rheumatology Group National Diagnostic Register. J. Rheumatol 1996, 23:1975-1980.
118. Peterson L.S., Mason T., Nelson A.M., et al. Juvenile rheumatoid arthritis in Rochester, Minnesota, 1960-1993: is the epidemiology changing?. Arthritis Rheum 1996, 39:1385-1390.
119. Fujikawa S., Okuni M. A nationwide surveillance study of rheumatic diseases among Japanese children. Acta. Paediatr. Jpn 1997, 39:242-244.
120. Ozen S., Karaaslan Y., Ozdemir O., et al. Prevalence of juvenile chronic arthritis and familial Mediterranean fever in Turkey: a field study. J. Rheumatol 1998, 25:2445-2449.
121. Moe N., Rygg M. Epidemiology of juvenile chronic arthritis in northern Norway: a ten-year retrospective study. Clin. Exp. Rheumatol 1998, 16:99-101.
122. Arguedas O, Fasth A, Andersson-Gare B, et al. Juvenile chronic arthritis in urban San Jose, Costa Rica: a 2-year prospective study. J. Rheumatol. 1998, 25:1844-1850.
123. Kiessling U., Doring E., Listing J., et al. Incidence and prevalence of juvenile chronic arthritis in East Berlin 1980-1988. J. Rheumatol 1998, 25:1837-1843.
124. Gare B.A. Epidemiology. Baillieres. Clin. Rheumatol 1998, 12:191-208.
125. Danner S., Sordet C., Terzic J., et al. Epidemiology of juvenile idiopathic arthritis in Alsace. J. Rheumatol 2006, 33:377-1381.
126. Adams B.S. Juvenile arthritis. More common than you think. Mich. Med 2001, 100:53-54.
127. Ansell B.M., Oration 1977 Heberden Chronic arthritis in childhood. Ann. Rheum. Dis 1978, 37:107-120.
128. Hill R.H. Juvenile arthritis in various racial groups in British Columbia. Arthritis Rheum 1977, 20:162.
129. Haffejee I.E., Raga J., Coovadia H.M. Juvenile chronic arthritis in black and Indian South African children. S. Afr. Med. J 1984, 65:510-514.
130. Graham T.B., Glass D.N. Juvenile rheumatoid arthritis: ethnic differences in diagnostic types. J. Rheumatol 1997, 24:1677-1679.
131. Schwartz M.M., Simpson P., Kerr K.L., et al. Juvenile rheumatoid arthritis in African Americans. J. Rheumatol 1997, 24:1826-1829.
132. Greenwood B.M. Polyarthritis in Western Nigeria. II. Still's disease. Ann. Rheum. Dis 1969, 28:617-623.
133. McGill P.E., Oyoo G.O. Rheumatic disorders in Sub-Saharan Africa. East. Afr. Med. J 2002, 79:214-216.
134. Kurahara D., Tokuda A., Grandinetti A., et al. Ethnic differences in risk for pediatric rheumatic illness in a culturally diverse population. J. Rheumatol 2002, 29:379-383.
135. Fujikawa S., Okuni M. Clinical analysis of 570 cases with juvenile rheumatoid arthritis: results of a nationwide retrospective survey in Japan. Acta. Paediatr. Jpn 1997, 39:245-249.
136. Aggarwal A., Misra R. Juvenile chronic arthritis in India: is it different from that seen in Western countries?. Rheumatol. Int 1994, 14:53-56.
137. Chandrasekaran A.N., Rajendran C.P., Madhavan R. Juvenile rheumatoid arthritis-Madras experience. Indian J. Pediatr 1996, 63:501-510.
138. Seth V., Kabra S.K., Semwal O.P., et al. Clinico-immunological profile in juvenile rheumatoid arthritis-an Indian experience. Indian. J. Pediatr 1996, 63:293-300.
139. Sauernmann R.K., Rose J.B., Tyrell P., et al. Epidemiology of juvenile idiopathic arthritis in a multiethnic cohort. Arthritis Rheum 2007, 56:1974-1984.
140. Rosenberg A.M., Petty R.E., Oen K.G., et al. Rheumatic diseases in Western Canadian Indian children. J. Rheumatol 1982, 9:589-592.
141. Oen K., Postl B., Chalmers I.M., et al. Rheumatic diseases in an Inuit population. Arthritis Rheum 1986, 29:65-74.
142. Boyer G.S., Lanier A.P., Templin D.W., et al. Spondyloarthropathy and rheumatoid arthritis in Alaskan Yupik Eskimos. J. Rheumatol 1990, 17:489-496.
143. Mason T., Rabinovich C.E., Fredrickson D.D., et al. Breast feeding and the development of juvenile rheumatoid arthritis. J. Rheumatol 1995, 22:1166-1170.
144. Rosenberg A.M. Evaluation of associations between breast feeding and subsequent development of juvenile rheumatoid arthritis. J. Rheumatol 1996, 23:1080-1082.
145. Jaakkola J.J.K., Gissler M. Maternal smoking in pregnancy is a determinant of RA and other inflammatory polyarthropathies in the first 7 years of life. International J. Epi 2005, 14:664-671.
146. Lang B.A., Shore A. A review of current concepts on the pathogenesis of juvenile rheumatoid arthritis. J. Rheumatol 1990, 21:1-15. Suppl.
147. Lipnick R.N., Tsokos G.C., Magilavy D.B. Immune abnormalities in the pathogenesis of juvenile rheumatoid arthritis. Rheum. Dis. Clin. North Am 1991, 17:843-857.
148. De Benedetti F., Ravelli A., Martini A. Cytokines in juvenile rheumatoid arthritis. Curr. Opin. Rheumatol 1997, 9:428-433.
149. Moore T.L. Immunopathogenesis of juvenile rheumatoid arthritis. Curr. Opin. Rheumatol 1999, 11:377-383.
150. De Benedetti F., Vivarelli M., Pignatti P., et al. Circulating levels of soluble E-selectin, P-selectin and intercellular adhesion molecule-1 in patients with juvenile idiopathic arthritis. J. Rheumatol 2000, 27:2246-2250.
151. Woo P. Cytokines and juvenile idiopathic arthritis. Curr. Rheumatol. Rep 2002, 4:452-457.
152. O'Neill L.A. Primer: Toll-like receptor signaling pathways: what do rheumatologists need to know?. Nature Clinical Practice Rheumatology 2008, 4:319-327.
153. Church L.D., Cook G.P., McDermott M.F. Primer: inflammasomes and interleukin 1 B in inflammatory disorders, Nature. Clinical Practice Rheumatology 2008, 4:34-42.
154. Jarvis J.N., Jiang L., Frank M.B., et al. Gene expression profiling in neutrophils from children with polyarticular juvenile idiopathic arthritis. Arthritis Rheum 2009, 60:1488-1495.
155. Frosch M., Ahlmann M., Vogl T., et al. The myeloid-related proteins 8 and 14 complex, a novel ligand of toll-like receptor 4 and interleukin 1 beta form a positive feedback mechanism in systemic onset juvenile idiopathic arthritis,. Arthritis Rheum 2009, 60:883-891.
156. Frosch M., Strey A., Vogl T., et al. Myeloid related proteins 8 and 14 during interaction of phagocytes and activated endothelium and are useful markers for monitoring disease activity in pauciarticular-onset juvenile rheumatoid arthritis. Arthritis Rheum 2000, 43:629-637.
157. Kanzler H., Barrat F.J., Hessell E.M., et al. Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists. Nature Medicine 2007, 13:552-559.
158. Foell D., Roth J. Proinflammatory S100 proteins in arthritis and autoimmune disease. Arthritis Rheum 2004, 50:3762-3771.
159. Pascual V., Allantaz F., Arce E., et al. Role of interleukin 1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis, and clinical response to IL-1 blockade. J. Exp. Med 2005, 201:1479-1486.
160. Stock C.J., Ogilvie E.M., Samuel J.M., et al. Comprehensive association study of genetic variants of the IL-1 gene family in systemic juvenile idiopathic arthritis. Genes Immunity 2008, 9:349-357.
161. Pauls J.D., Silverman E., Laxer R.M., et al. Antibodies to histones H1 and H5 in sera of patients with juvenile rheumatoid arthritis. Arthritis Rheum 1989, 32:877-883.
162. Malleson P., Petty R.E., Fung M., et al. Reactivity of antinuclear antibodies with histones and other antigens in juvenile rheumatoid arthritis. Arthritis Rheum 1989, 32:919-923.
163. Monestier M., Losman J.A., Fasy T.M., et al. Antihistone antibodies in antinuclear antibody-positive juvenile arthritis. Arthritis. Rheum 1990, 33:1836-1841.
164. Leak A.M., Woo P. Juvenile chronic arthritis, chronic iridocyclitis, and reactivity to histones. Ann. Rheum. Dis 1991, 50:653-657.
165. Malleson P.N., Fung M.Y., Petty R.E., et al. Autoantibodies in chronic arthritis of childhood: relations with each other and with histocompatibility antigens. Ann. Rheum. Dis 1992, 51:1301-1306.
166. Leak A.M., Tuaillon N., Muller S., et al. Study of antibodies to histones and histone synthetic peptides in pauciarticular juvenile chronic arthritis. Br. J. Rheumatol 1993, 32:426-431.
167. Stemmer C., Tuaillon N., Prieur A.M., et al. Mapping of B-cell epitopes recognized by antibodies to histones in subsets of juvenile chronic arthritis. Clin. Immunol. Immunopathol 1995, 76:82-89.
168. Speckmaier M., Rother E., Terreri T., et al. Prevalence of anti-neutrophil cytoplasmic antibodies (ANCA) in juvenile chronic arthritis. Clin. Exp. Rheumatol 1996, 14:211-216.
169. Mulder L., Van Rossum M., Horst G., et al. Antineutrophil cytoplasmic antibodies in juvenile chronic arthritis. J. Rheumatol 1997, 24:568-575.
170. Bakkaloglu A., Ozen S., Saatci U., et al. Antineutrophil cytoplasmic antibodies in juvenile chronic arthritis. Clin. Rheumatol 1999, 18:304-307.
171. Gabay C., Prieur A.M., Meyer O. Occurrence of antiperinuclear, antikeratin, and anti-RA 33 antibodies in juvenile chronic arthritis. Ann. Rheum. Dis 1993, 52:785-789.
172. Serra C.R., Rodrigues S.H., Sztajnbok F.R., et al. Antiperinuclear factor and antibodies to the stratum corneum of rat esophagus in juvenile idiopathic arthritis. J. Pediatr 1999, 134:507-509.
173. Hromadnikova I., Vavrincova P., Stechova K., et al. Anti-keratin antibodies in patients with juvenile idiopathic arthritis. Clin. Exp. Rheumatol 2001, 19:470-473.
174. Caporali R., Ravelli A., De Gennaro F., et al. Prevalence of anticardiolipin antibodies in juvenile chronic arthritis. Ann. Rheum. Dis 1991, 50:599-601.
175. Gattorno M., Buoncompagni A., Molinari A.C., et al. Antiphospholipid antibodies in paediatric systemic lupus erythematosus, juvenile chronic arthritis and overlap syndromes: SLE patients with both lupus anticoagulant and high-titre anticardiolipin antibodies are at risk for clinical manifestations related to the antiphospholipid syndrome. Br. J. Rheumatol 1995, 34:873-881.
176. Serra C.R., Rodrigues S.H., Silva N.P., et al. Clinical significance of anticardiolipin antibodies in juvenile idiopathic arthritis. Clin. Exp. Rheumatol 1999, 17:375-380.
177. Dong X., Wang J., Kabir F.N., et al. Autoantibodies to DEK oncoprotein in human inflammatory disease. Arthritis Rheum 2000, 43:85-93.
178. Wittemann B., Neuer G., Michels H., et al. Autoantibodies to nonhistone chromosomal proteins HMG-1 and HMG-2 in sera of patients with juvenile rheumatoid arthritis. Arthritis Rheum 1990, 33:1378-1383.
179. Neuer G., Bustin M., Michels H., et al. Autoantibodies to the chromosomal protein HMG-17 in juvenile rheumatoid arthritis. Arthritis Rheum 1992, 35:472-475.
180. Neuer G., Bautz F.A., Bustin M., et al. Sera from JRA patients contain antibodies against a defined epitope in chromosomal protein HMG-17. Autoimmunity 1994, 17:23-30.
181. Jung F., Neuer G., Bautz F.A. Antibodies against a peptide sequence located in the linker region of the HMG-1/2 box domains in sera from patients with juvenile rheumatoid arthritis. Arthritis Rheum 1997, 40:1803-1809.
182. Rosenberg A.M., Cordeiro D.M. Relationship between sex and antibodies to high mobility group proteins 1 and 2 in juvenile idiopathic arthritis. J. Rheumatol 2000, 27:2489-2493.
183. Rosenberg A.M., Hunt D.W., Petty R.E. Antibodies to native type I collagen in childhood rheumatic diseases. J. Rheumatol 1984, 11:421-424.
184. Petty R.E., Hunt D.W., Rosenberg A.M. Antibodies to type IV collagen in rheumatic diseases. J. Rheumatol 1986, 13:246-253.
185. Myers L.K., Higgins G.C., Finkel T.H., et al. Juvenile arthritis and autoimmunity to type II collagen. Arthritis Rheum 2001, 44:1775-1781.
186. Guerassimov A., Duffy C., Zhang Y., et al. Immunity to cartilage link protein in patients with juvenile rheumatoid arthritis. J. Rheumatol 1997, 24:959-964.
187. Pellegrini G., Scotta M.S., Soardo S., et al. Elevated IgA anti-gliadin antibodies in juvenile chronic arthritis. Clin. Exp. Rheumatol 1991, 9:653-656.
188. Lepore L., Pennesi M., Ventura A., et al. Anti-alpha-gliadin antibodies are not predictive of celiac disease in juvenile chronic arthritis. Acta. Paediatr 1993, 82:569-573.
189. Van Rossum M., van Soesbergen R., de Kort S., et al. Anti-cyclic citrullinated peptide (anti-CCP) antibodies in children with juvenile idiopathic arthritis. J. Rheumatol 2003, 30:825-828.
190. Avcin T., Cimaz R., Falcini F., et al. Prevalence and clinical significance of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis. Ann. Rheum. Dis 2002, 61:608-611.
191. Rossen R.D., Brewer E.J., Person D.A., et al. Circulating immune complexes and antinuclear antibodies in juvenile rheumatoid arthritis. Arthritis Rheum 1977, 20:1485-1490.
192. Moran H., Ansell B.M., Mowbray J.F., et al. Antigen-antibody complexes in the serum of patients with juvenile chronic arthritis. Arch. Dis. Child 1979, 54:120-122.
193. Khalkhali-Ellis Z., Bulla G.A., Schlesinger L.S., et al. C1q-containing immune complexes purified from sera of juvenile rheumatoid arthritis patients mediate IL-8 production by human synoviocytes: role of C1q receptors. J. Immunol 1999, 163:4612-4620.
194. Jarvis J.N., Taylor H., Iobidze M., et al. Complement activation and immune complexes in children with polyarticular juvenile rheumatoid arthritis: a longitudinal study. J. Rheumatol 1994, 21:1124-1127.
195. Aggarwal A., Bhardwaj A., Alam S., et al. Evidence for activation of the alternate complement pathway in patients with juvenile rheumatoid arthritis. Rheumatology (Oxf.) 2000, 39:189-192.
196. Wouters C.H., Ceuppens C.L., Stevens E.A. Different circulating lymphocyte profiles in patients with different subsets of juvenile idiopathic arthritis. Clin. Exp. Rheum 2002, 20:239-248.
197. Bergroth V., Konttinen Y.T., Pelkonen P., et al. Synovial fluid lymphocytes in different subtypes of juvenile rheumatoid arthritis. Arthritis Rheum 1988, 31:780-783.
198. Odum N., Morling N., Platz P., et al. Increased prevalence of late stage T cell activation antigen (VLA-1) in active juvenile chronic arthritis. Ann. Rheum. Dis 1987, 46:846-852.
199. Forre O., Thoen J., Dobloug J.H., et al. Detection of T-lymphocyte subpopulation in the peripheral blood and the synovium of patients with rheumatoid arthritis and juvenile rheumatoid arthritis using monoclonal antibodies. Scand. J. Immunol 1982, 15:221-226.
200. Tsokos G.C., Inghirami G., Pillemer S.R., et al. Immunoregulatory aberrations in patients with polyarticular juvenile rheumatoid arthritis. Clin. Immunol. Immunopathol 1988, 47:62-74.
201. Massa M., De Benedetti F., Robbioni P., et al. Association of methotrexate treatment with a decrease of double negative (CD4-CD8-) and gamma/delta T cell levels in patients with juvenile rheumatoid arthritis. J. Rheumatol 1993, 20:1944-1948.
202. Thoen J., Forre O., Waalen K., et al. Phenotypes of T lymphocytes from peripheral blood and synovial fluid of patients with rheumatoid arthritis and juvenile rheumatoid arthritis. evidence in favour of
203. Wedderburn L.R., Robinson N., Patel A., et al. Selective recruitment of polarized T cells expressing CCR5 and CXCR3 to the inflamed joints of children with juvenile idiopathic arthritis. Arthritis Rheum 2000, 43:765-774.
204. Scola M.P., Thompson S.D., Brunner H.I., et al. Interferon-gamma:interleukin-4 ratios and associated type 1 cytokine expression in juvenile rheumatoid arthritis synovial tissue. J. Rheumatol 2002, 29:369-378.
205. Murray K.J., Luyrink L., Grom A.A., et al. Immunohistological characteristics of T cell infiltrates in different forms of childhood onset chronic arthritis. J. Rheumatol 1996, 23:2116-2124.
206. Murray K.J., Grom A.A., Thompson S.D., et al. Contrasting cytokine profiles in the synovium of different forms of juvenile rheumatoid arthritis and juvenile spondyloarthropathy: prominence of interleukin 4 in restricted disease. J. Rheumatol 1998, 25:1388-1398.
207. Chini L., Bardare M., Cancrini C., et al. Evidence of clonotypic pattern of T-cell repertoire in synovial fluid of children with juvenile rheumatoid arthritis at the onset of the disease. Scand. J. Immunol 2002, 56:512-517.
208. Grom A.A., Murray K.J., Luyrink L., et al. Patterns of expression of tumor necrosis factor alpha, tumor necrosis factor beta, and their receptors in synovia of patients with juvenile rheumatoid arthritis and juvenile spondyloarthropathy. Arthritis Rheum 1996, 39:1703-1710.
209. Muzaffer M.A., Dayer J.M., Feldman B.M., et al. Differences in the profiles of circulating levels of soluble tumor necrosis factor receptors and interleukin 1 receptor antagonist reflect the heterogeneity of the subgroups of juvenile rheumatoid arthritis. J. Rheumatol 2002, 29:1071-1078.
210. Ozen S., Tucker L.B., Miller L.C. Identification of Th subsets in juvenile rheumatoid arthritis confirmed by intracellular cytokine staining. J. Rheumatol 1998, 25:1851-1853.
211. Thompson S.D., Luyrink L.K., Graham T.B., et al. Chemokine receptor CCR4 on CD4+ T cells in juvenile rheumatoid arthritis synovial fluid defines a subset of cells with increased IL-4 IFN-gamma mRNA ratios. J. Immunol 2001, 166:6899-6906.
212. Varsani H., Patel A., van Kooyk Y., et al. Synovial dendritic cells in juvenile idiopathic arthritis (JIA) express receptor activator of NF-kappaB (RANK). Rheumatology (Oxf.) 2003, 42:583-590.
213. Gattorno M., Facchetti P., Ghiotto F., et al. Synovial fluid T cell clones from oligoarticular juvenile arthritis patients display a prevalent Th1/Th0-type pattern of cytokine secretion irrespective of immunophenotype. Clin. Exp. Immunol 1997, 109:4-11.
214. Raziuddin S., Bahabri S., Al Dalaan A., et al. A mixed Th1/Th2 cell cytokine response predominates in systemic onset juvenile rheumatoid arthritis: immunoregulatory IL-10 function,. Clin. Immunol. Immunopathol 1998, 86:192-198.
215. Oglivie E.M., Fife M.S., Thompson S.D., et al. TDT association study confirms the IL6-174 SNP confers susceptibility to systemic JIA. Arthritis Rheum 2002, 46(suppl):S578.
216. Jefferey R., Luong L., Ogilvie E., et al. The -174 single nucleotide polymorphism (SNP) of the interleukin-6 gene associated with systemic arthritis is functionally significant in the control of common haplotypes, alters transcription factor binding and repression by glucocorticoids,. Arthritis Rheum 2002, 46(suppl):S578.
217. Meazza C., Travaglino P., Pignatti P., et al. Macrophage migration inhibitory factor in patients with juvenile idiopathic arthritis. Arthritis Rheum 2002, 46:232-237.
218. De Benedetti F., Meazza C., Vivarelli M., et al. Functional and prognostic significance of the -173 polymorphism of the macrophage migration inhibitory factor (MIF) gene in systemic JIA. Arthritis Rheum 2002, 46(suppl):S580.
219. Zeggini E., Thomson W., Kwiatkowski D., et al. Linkage and association studies of single-nucleotide polymorphism-tagged tumor necrosis factor haplotypes in juvenile oligoarthritis. Arthritis Rheum 2002, 46:3304-3311.
220. DeBenedatti F., Pignatti P., Gerloni V., et al. Differences in synovial fluid cytokine levels between juvenile and adult rheumatoid arthritis. J. Rheumatol 1997, 24:1403-1409.
221. Ozen S., Alikasifoglu M., Bakkaloglu A., et al. Tumour necrosis factor alpha G → A -238 and G → A -308 polymorphisms in juvenile idiopathic arthritis. Rheumatology (Oxf.) 2002, 41:223-227.
222. Woo P. Cytokines in juvenile chronic arthritis. Baillieres. Clin. Rheumatol 1998, 12:219-228.
223. Harjacek M., Diaz-Cano S., Alman B.A., et al. Prominent expression of mRNA for proinflammatory cytokines in synovium in patients with juvenile rheumatoid arthritis or chronic Lyme arthritis. J. Rheumatol 2000, 27:497-503.
224. De Benedetti F., Martini A. Is systemic juvenile rheumatoid arthritis an interleukin 6 mediated disease?. J. Rheumatol 1998, 25:203-207.
225. Mangge H., Schauenstein K. Cytokines in juvenile rheumatoid arthritis (JRA). Cytokine 1998, 10:471-480.
226. Rooney M., Varsani H., Martin K., et al. Tumour necrosis factor alpha and its soluble receptors in juvenile chronic arthritis. Rheumatology (Oxf.) 2000, 39:432-438.
227. Yokota S., Interleukin 6 as a therapeutic target in systemic-onset juvenile idiopathic arthritis. Curr. Opin. Rheumatol 2003, 15:581-586.
228. Donn R., Alourfi Z., Zeggini E., et al. A functional promoter haplotype of macrophage migration inhibitory factor is linked and associated with juvenile idiopathic arthritis,. Arthritis Rheum 2004, 50:1604-1610.
229. Sioud M., Kjeldsen-Kragh J., Suleyman S., et al. Limited heterogeneity of T cell receptor variable region gene usage in juvenile rheumatoid arthritis synovial T cells. Eur. J. Immunol 1992, 22:2413-2418.
230. Thompson S.D., Murray K.J., Grom A.A., et al. Comparative sequence analysis of the human T cell receptor beta chain in juvenile rheumatoid arthritis and juvenile spondylarthropathies: evidence for antigenic selection of T cells in the synovium. Arthritis Rheum 1998, 41:482-497.
231. Maksymowych W.P., Gabriel C.A., Luyrink L., et al. Polymorphism in a T-cell receptor variable gene is associated with susceptibility to a juvenile rheumatoid arthritis subset. Immunogenetics 1992, 35:257-262.
232. Grom A.A., Von Knorre C., Murray K.J., et al. T-cell receptor BV6S1 null alleles and HLA-DR1 haplotypes in polyarticular outcome juvenile rheumatoid arthritis. Hum. Immunol 1996, 45:152-156.
233. Ploski R., Hansen T., Forre O. Lack of association with T-cell receptor TCRBV6S1 2 allele in HLA-DQA 10101-positive Norwegian juvenile chronic arthritis patients. Immunogenetics 1993, 38:444-445.
234. Nepom B.S., Malhotra U., Schwarz D.A., et al. HLA and T cell receptor polymorphisms in pauciarticular-onset juvenile rheumatoid arthritis. Arthritis Rheum 1991, 34:1260-1267.
235. Neeck G., Michels H. Endocrine aspects of paediatric rheumatic diseases. Baillieres. Clin. Rheumatol 1996, 10:349-363.
236. Chikanza I.C., Kuis W., Heijnen C.J. The influence of the hormonal system on pediatric rheumatic diseases,. Rheum. Dis. Clin. North Am 2000, 26:911-925.
237. Khalkhali-Ellis Z., Moore T.L., Hendrix M.J. Reduced levels of testosterone and dehydroepiandrosterone sulphate in the serum and synovial fluid of juvenile rheumatoid arthritis patients correlates with disease severity. Clin. Exp. Rheumatol 1998, 16:753-756.
238. Da Silva J.A., Larbre J.P., Spector T.D., et al. Protective effect of androgens against inflammation induced cartilage degradation in male rodents. Ann. Rheum. Dis 1993, 52:285-291.
239. Chikanza I.C. Prolactin and neuroimmunomodulation: in vitro and in vivo observations. Ann. N. Y. Acad. Sci 1999, 876:119-130.
240. McMurray R.W., Allen S.H., Pepmueller P.H., et al. Elevated serum prolactin levels in children with juvenile rheumatoid arthritis and antinuclear antibody seropositivity. J. Rheumatol 1995, 22:1577-1580.
241. Picco P., Gattorno M., Buoncompagni A., et al. Interactions between prolactin and the proinflammatory cytokine network in juvenile chronic arthritis. Ann. N. Y. Acad. Sci 1999, 876:262-265.
242. Maillefert J.F., Tonolli-Serabian I., Cherasse A., et al. Arthritis following combined vaccine against diphtheria, polyomyelitis, and tetanus toxoid. Clin. Exp. Rheumatol 2000, 18:255-256.
243. Weibel R.E., Benor D.E. Chronic arthropathy and musculoskeletal symptoms associated with rubella vaccines. A review of 124 claims submitted to the National Vaccine Injury Compensation Program [published erratum appears in Arthritis Rheum 39:1930, 1996],. Arthritis Rheum 1996, 39:1529-1534.
244. Pritchard M.H., Matthews N., Munro J. Antibodies to influenza A in a cluster of children with juvenile chronic arthritis. Br. J. Rheumatol 1988, 27:176-180.
245. Pritchard M.H., Munro J. Successful treatment of juvenile chronic arthritis with a specific antiviral agent. Br. J. Rheumatol 1989, 28:521-524.
246. Schwarz T.F., Roggendorf M., Suschke H., et al. Human parvovirus B19 infection and juvenile chronic polyarthritis. Infection 1987, 15:264-265.
247. Nocton J.J., Miller L.C., Tucker L.B., et al. Human parvovirus B19-associated arthritis in children. J. Pediatr 1993, 122:186-190.
248. Soderlund M., Von Essen R., Haapasaari J., et al. Persistence of parvovirus B19 DNA in synovial membranes of young patients with and without chronic arthropathy. Lancet 1997, 349:1063-1065.
249. Oguz F., Akdeniz C., Unuvar E., et al. Parvovirus B19 in the acute arthropathies and juvenile rheumatoid arthritis. J. Paediatr. Child Health 2002, 38:358-362.
250. Gonzales B., Larranaga C., León O., et al. Parvovirus B19 may have a role in the pathogenesis of juvenile idiopathic arthritis. J. Rheum 2007, 34:1336-1340.
251. Chinniah K., Mody G., Bhimma R., et al. Arthritis in association with human immunodeficiency virus infection in black African children: causal or coincidental?. Rheumatology (Oxford) 2005, 44:915-920.
252. Graeff-Meeder E.R., Van Eden W., Rijkers G.T., et al. Heat-shock proteins and juvenile chronic arthritis. Clin. Exp. Rheumatol 1993, 11(suppl. 9):S25-S28.
253. Life P., Hassell A., Williams K., et al. Responses to gram negative enteric bacterial antigens by synovial T cells from patients with juvenile chronic arthritis: recognition of heat shock protein HSP60. J. Rheumatol 1993, 20:1388-1396.
254. Albani S., Ravelli A., Massa M., et al. Immune responses to the Escherichia coli dnaJ heat shock protein in juvenile rheumatoid arthritis and their correlation with disease activity. J. Pediatr 1994, 124:561-565.
255. Prakken A.B., Van Hoeij M.J., Kuis W., et al. T-cell reactivity to human HSP60 in oligo-articular juvenile chronic arthritis is associated with a favorable prognosis and the generation of regulatory cytokines in the inflamed joint. Immunol. Lett 1997, 57:139-142.
256. Zlacka D., Vavrincova P., Hein Nguyen T.T., et al. Frequency of anti hsp-60, 65 and 70 antibodies in patients with juvenile idiopathic arthritis. J. Autoimmunity 2006, 27:81-88.
257. Conroy S.E., Tucker L., Latchman D.S., et al. Incidence of anti Hsp 90 and 70 antibodies in children with SLE, juvenile dermatomyositis and juvenile chronic arthritis. Clin. Exp. Rheumatol 1996, 14:99-104.
258. Prakken B., Kuis W., Van Eden W., et al. Heat shock proteins in juvenile idiopathic arthritis: keys for understanding remitting arthritis and candidate antigens for immune therapy. Curr. Rheumatol. Rep 2002, 4:466-473.
259. Van Eden W., Van der Zee R., Taams L.S., et al. Heat-shock protein T-cell epitopes trigger a spreading regulatory control in a diversified arthritogenic T-cell response. Immunol. Rev 1998, 164:169-174.
260. Prakken A.B., Van Eden W., Rijkers G.T., et al. Autoreactivity to human heat-shock protein 60 predicts disease remission in oligoarticular juvenile rheumatoid arthritis. Arthritis Rheum 1996, 39:1826-1832.
261. De Kleer I.M., Kamphuis S.M., Rijkers G.T., et al. The spontaneous remission of juvenile idiopathic arthritis is characterized by CD30+ T cells directed to human heat-shock protein 60 capable of producing the regulatory cytokine interleukin-10,. Arthritis Rheum 2003, 48:2001-2010.
262. Albani S., Keystone E.C., Nelson J.L., et al. Positive selection in autoimmunity: abnormal immune responses to a bacterial dnaJ antigenic determinant in patients with early rheumatoid arthritis. Nat. Med 1995, 1:448-452.
263. Danieli M.G., Markovits D., Gabrielli A., et al. Juvenile rheumatoid arthritis patients manifest immune reactivity to the mycobacterial 65-kDa heat shock protein, to its 180-188 peptide, and to a partially homologous peptide of the proteoglycan link protein. Clin. Immunol. Immunopathol 1992, 64:121-128.
264. Nuallain E.M., Monaghan H., Reen D.J. Antibody response of restricted isotype to heat shock proteins in juvenile chronic arthritis. Scand. J. Immunol 1993, 38:83-88.
265. Albani S. Infection and molecular mimicry in autoimmune diseases of childhood. Clin. Exp. Rheumatol 1994, 12(suppl. 10):S35-S41.
266. Vandvik I.H., Hoyeraal H.M., Fagertun H. Chronic family difficulties and stressful life events in recent onset juvenile arthritis. J. Rheumatol 1989, 16:1088-1092.
267. Kuis W., Kavelaars A., Prakken B.J., et al. Dialogue between the brain and the immune system in juvenile chronic arthritis, Rev. Rhum. Engl. Ed 1997, 64:146S-148S.
268. Donn R.P., Farhan A., Stevans A., et al. Neuroendocrine gene polymorphisms and susceptibility to juvenile idiopathic arthritis. Rheumatology (Oxf.) 2002, 41:930-936.
269. Pearson C.M. Development of arthritis, periarthritis and periostitis in rats given adjuvants. Proc. Soc. Exp. Biol. Med 1956, 91:95-101.
270. Waksman B.H., Bullington S.J. Studies of arthritis and other lesions induced in rats by injection of mycobacterial adjuvant. III. Lesions of the eye. Arch. Ophthalmol 1960, 64:751-762.
271. Holoshitz J., Naparstek Y., Ben Nun A., et al. Lines of T lymphocytes induce or vaccinate against autoimmune arthritis. Science 1983, 219:56-58.
272. Van Eden W., Holoshitz J., Nevo Z., et al. Arthritis induced by a T-lymphocyte clone that responds to Mycobacterium tuberculosis and to cartilage proteoglycans. Proc. Natl. Acad. Sci. U. S. A 1985, 82:5117-5120.
273. Zidek Z., Masek K., Jiricka Z. Arthritogenic activity of a synthetic immunoadjuvant, muramyl dipeptide. Infect. Immun 1982, 35:674-679.
274. Cremer M.A., Rosloniec E.F., Kang A.H. The cartilage collagens: a review of their structure, organization, and role in the pathogenesis of experimental arthritis in animals and in human rheumatic disease,. J. Mol. Med 1998, 76:275-288.
275. Stuart J.M., Townes A.S., Kang A.H. Collagen autoimmune arthritis. Annu. Rev. Immunol 1984, 2:199-218.
276. Staines N.A., Harper N., Ward F.J., et al. Arthritis: animal models of oral tolerance. Ann. N. Y. Acad. Sci 1996, 778:297-305.
277. Drew R.A. Erysipelothrix arthritis in pigs as a comparative model for rheumatoid arthritis. Proc. R. Soc. Med 1972, 65:994-998.
278. Cole B.C. Mycoplasma induced arthritis in animals: relevance. to understanding the etiologies of the human rheumatic diseases. Rev. Rhum. Engl. Ed 1999, 66:45S-49S.
279. Storz J. Chlamydia and chlamydia-induced diseases 1971, Charles C Thomas, Springfield, IL.
280. Walker E.R., Friedman M.H., Olson N.O., et al. Ultrastructural study of avian synovium infected with an arthrotropic reovirus. Arthritis Rheum 1977, 20:1269-1277.
281. Hanson J., Hydbring E., Olsson K. A long term study of goats naturally infected with caprine arthritis-encephalitis virus,. Acta. Vet. Scand 1996, 37:31-39.
282. Pedersen N.C., Castles J.J., Weisner K. Noninfectious canine arthritis: rheumatoid arthritis. J. Am. Vet. Med. Assoc 1976, 169:295-303.
283. Hang L., Theofilopoulos A.N., Dixon F.J. A spontaneous rheumatoid arthritis-like disease in MRL/l mice,. J. Exp. Med 1982, 155:1690-1701.
284. De Benedetti F., Meazza C., Oliveri M., et al. Effect of IL-6 on IGF binding protein-3: a study in IL-6 transgenic mice and in patients with systemic juvenile idiopathic arthritis. Endocrinology 2001, 142:4818-4826.
285. Li P., Schwarz E.M., O'Keefe R.J., et al. Systemic tumor necrosis factor alpha mediates an increase in peripheral CD11 high osteoclast precursors in tumor necrosis factor alpha-transgenic mice. Arthritis Rheum 2004, 50:265-276.
286. Zwerina J., Hayer S., Tohidast-Akrad M., et al. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction. Arthritis Rheum 2004, 50:277-290.
287. Phelan J.D., Thompson S.D., Glass D.N. Susceptibility to JRA/JIA: complementing general autoimmune and arthritis traits. Genes Immun 2006, 7:1-10.
288. Moroldo M.B., Tague B.L., Shear E.S., et al. Juvenile rheumatoid arthritis in affected sibpairs. Arthritis Rheum 1997, 40:1962-1966.
289. Rosenberg A.M., Petty R.E. Similar patterns of juvenile rheumatoid arthritis within families. Arthritis Rheum 1980, 23:951-953.
290. Prahalad S., Fraser A.M., O'Brien E., et al. Lack of association between birth order and juvenile idiopathic arthritis. Arthritis Rheum 2003, 48:2989-2990.
291. Husby G., Williams R.C., Tung K.S., et al. Immunologic studies in identical twins concordant for juvenile rheumatoid arthritis but discordant for monoclonal gammopathy and amyloidosis. J. Lab. Clin. Med 1988, 111:307-314.
292. Prahalad S., Ryan M.H., Shear E.S., et al. Twins concordant for juvenile rheumatoid arthritis. Arthritis Rheum 2000, 43:2611-2612.
293. Prahalad S., Ryan M.H., Shear E.S., et al. Juvenile rheumatoid arthritis: linkage to HLA demonstrated by allele sharing in affected sibpairs. Arthritis Rheum 2000, 43:2335-2338.
294. Nepom B. The immunogenetics of juvenile rheumatoid arthritis,. Rheum. Dis. Clin. North Am 1991, 17:825-842.
295. Clemens L.E., Albert E., Ansell B.M. Sibling pairs affected by chronic arthritis of childhood: evidence for a genetic predisposition. J. Rheumatol 1985, 12:108-113.
296. Prahalad S., Shear E.S., Thompson S.D., et al. Increased prevalence of familial autoimmunity in simplex and multiplex families with juvenile rheumatoid arthritis. Arthritis Rheum 2002, 46:1851-1856.
297. Saila H., Savolainen A., Kauppi M., et al. Occurrence of chronic inflammatory rheumatic diseases among parents of multiple offspring affected by juvenile idiopathic arthritis. Clin. Exp. Rheumatol 2003, 21:263-265.
298. Rossen R.D., Brewer E.J., Sharp R.M., et al. Familial rheumatoid arthritis: linkage of HLA to disease susceptibility locus in four families where proband presented with juvenile rheumatoid arthritis. J. Clin. Invest 1980, 65:629-642.
299. Southwood T.R., Roberts-Thomson P.J., Ahern M.J., et al. Autoantibodies in patients with juvenile chronic arthritis and their immediate family relatives. Ann. Rheum. Dis 1990, 49:968-972.
300. Murray K.J., Moroldo M.B., Donnelly P., et al. Age-specific effects of juvenile rheumatoid arthritis-associated HLA alleles. Arthritis Rheum 1999, 42:1843-1853.
301. Hall P.J., Burman S.J., Laurent M.R., et al. Genetic susceptibility to early onset pauciarticular juvenile chronic arthritis: a study of HLA and complement markers in 158 British patients. Ann. Rheum. Dis 1986, 45:464-474.
302. Oen K., Petty R.E., Schroeder M- L. An association between HLA-A2 and juvenile rheumatoid arthritis in girls. J. Rheumatol 1982, 9:916-920.
303. Moroldo M.B., Donnelly P., Saunders J., et al. Transmission disequilibrium as a test of linkage and association between HLA alleles and pauciarticular-onset juvenile rheumatoid arthritis. Arthritis Rheum 1998, 41:1620-1624.
304. Smerdel A., Lie B.A., Ploski R., et al. A gene in the telomeric HLA complex distinct from HLA-A is involved in predisposition to juvenile idiopathic arthritis,. Arthritis Rheum 2002, 46:1614-1619.
305. Thomson W., Barrett J.H., Donn R., et al. Juvenile idiopathic arthritis classified by the ILAR criteria: HLA associations in UK patients. Rheumatology (Oxf.) 2002, 41:1183-1189.
306. Arnaiz-Villena A., Gomez-Reino J.J., Gamir M.L., et al. DR, C4, and Bf allotypes in juvenile rheumatoid arthritis. Arthritis Rheum 1984, 27:1281-1285.
307. Vicario J.L., Martinez-Laso J., Gomez-Reino J.J., et al. Both HLA class II and class III DNA polymorphisms are linked to juvenile rheumatoid arthritis susceptibility. Clin. Immunol. Immunopathol 1990, 56:22-28.
308. Hinks A., Barton A., John S., et al. Association between PTPN22 and rheumatoid arthritis and juvenile idiopathic arthritis in a UK population. Arthritis Rheum 2005, 52:1694-1699.
309. Hinks A., Ke X., Barton A., et al. Association of the IL2RA CD25 gene with juvenile idiopathic arthritis. Arthritis Rheum 2009, 60:251-257.
310. Rosen P., Thompson S., Glass D. Non-HLA gene polymorphisms in juvenile rheumatoid arthritis. Clin. Exp. Rheumatol 2003, 21:650-656.
311. Donn R.P., Davies E.J., Holt P.L., et al. Increased frequency of TAP2B in early onset pauciarticular juvenile chronic arthritis. Ann. Rheum. Dis 1994, 53:261-264.
312. Ploski R., Undlien D.E., Vinje O., et al. Polymorphism of human major histocompatibility complex-encoded transporter associated with antigen processing (TAP) genes and susceptibility to juvenile rheumatoid arthritis. Hum. Immunol 1994, 39:54-60.
313. Ploski R., McDowell T.L., Symons J.A., et al. Interaction between HLA-DR and HLA-DP, and between HLA and interleukin 1 alpha in juvenile rheumatoid arthritis indicates heterogeneity of pathogenic mechanisms of the disease. Hum. Immunol 1995, 42:343-347.
314. McDowell T.L., Symons J.A., Ploski R., et al. A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1 alpha polymorphism,. Arthritis Rheum 1995, 38:221-228.
315. Pryhuber K.G., Murray K.J., Donnelly P., et al. Polymorphism in the LMP2 gene influences disease susceptibility and severity in HLA-B27 associated juvenile rheumatoid arthritis. J. Rheumatol 1996, 23:747-752.
316. Prahalad S., Kingsbury D.J., Griffin T.A., et al. Polymorphism in the MHC-encoded LMP7 gene: association with JRA without functional significance for immunoproteasome assembly. J. Rheumatol 2001, 28:2320-2325.
317. Falcini F., Simonini G., Cimaz R., et al. Osteoprotegerin serum levels and osteoprotegerin polymorphism in juvenile idiopathic arthritis: correlations with articular erosions and low bone mass. Arthritis Rheum 2002, 46(suppl):S579.
318. Ihnat D.H., McIlvain-Simpson G., Conard K., et al. Inflammatory arthropathies in children with chromosomal abnormalities. J. Rheumatol 1993, 20:742-746.
319. Rudolf M.C., Genel M., Tamborlane W.V., et al. Juvenile rheumatoid arthritis in children with diabetes mellitus. J. Pediatr 1981, 99:519-524.
320. Agrawal S., Desai M.P. Simultaneous occurrence of type I diabetes mellitus and juvenile rheumatoid arthritis. Indian Pediatr 2003, 40:568-571.
321. Glass J.B., Sher P.K., Lennon V.A., et al. The association of pauciarticular juvenile arthritis and myasthenia gravis,. Am. J. Dis. Child 1991, 145:1176-1180.
322. Mihailova D., Grigorova R., Vassileva B., et al. Autoimmune thyroid disorders in juvenile chronic arthritis and systemic lupus erythematosus. Adv. Exp. Med. Biol 1999, 455:55-60.
323. Petty R.E., Malleson P., Kalousek D.K. Chronic arthritis in two children with partial deletion of chromosome 18. J. Rheumatol 1987, 14:586-587.
324. Sullivan K.E., McDonald-McGinn D.M., Driscoll D.A., et al. Juvenile rheumatoid arthritis-like polyarthritis in chromosome 22q11.2 deletion syndrome (DiGeorge anomalad/velocardiofacial syndrome/conotruncal anomaly face syndrome). Arthritis Rheum 1997, 40:430-436.
325. Wihlborg C.E., Babyn P.S., Schneider R. The association between Turner's syndrome and juvenile rheumatoid arthritis,. Pediatr. Radiol 1999, 29:676-681.
326. Zulian F., Schumacher H.R., Calore A., et al. Juvenile arthritis in Turner's syndrome: a multicenter study. Clin. Exp. Rheumatol 1998, 16:489-494.
327. Zamir G., Press J., Tal A., et al. Sleep fragmentation in children with juvenile rheumatoid arthritis. J. Rheumatol 1998, 25:1191-1197.
328. Bloom B.J., Owens J.A., McGuinn M., et al. Sleep and its relationship to pain, dysfunction, and disease activity in juvenile rheumatoid arthritis. J. Rheumatol 2002, 29:169-173.
329. Passarelli C.M., Roizenblatt S., Len C.A., et al. A case-control sleep study in children with polyarticular juvenile rheumatoid arthritis,. J. Rheumatol 2006, 33:796-802.
330. Ward T.M., Brandt P., Archbold K., et al. Polysomnography and self-reported sleep, pain, fatigue and anxiety in children with active and inactive juvenile rheumatoid arthritis. J. Pediatr. Psychol 2008, 33:332-341.
331. Anthony K.K., Schanberg L.E. Assessment and management of pain syndromes and arthritis pain in children and adolescents. Rheum. Dis. Clin. North Am 2007, 33:625-660.
332. Hagglund K.J., Schopp L.M., Alberts K.R., et al. Predicting pain among children with juvenile rheumatoid arthritis. Arthritis Care Res 1995, 8:36-42.
333. Kuis W., Heijnen C.J., Hogeweg J.A., et al. How painful is juvenile chronic arthritis?. Arch. Dis. Child 1997, 77:451-453.
334. Cabral D.A., Tucker L.B. Malignancies in children who initially present with rheumatic complaints. J. Pediatr 1999, 134:53-57.
335. Ilowite N.T., Walco G.A., Pochaczevsky R. Assessment of pain in patients with juvenile rheumatoid arthritis: relation between pain intensity and degree of joint inflammation. Ann. Rheum. Dis 1992, 51:343-346.
336. Thastum M., Zachariae R., Scholer M., et al. Cold pressor pain: comparing responses of juvenile arthritis patients and their parents. Scand. J. Rheumatol 1997, 26:272-279.
337. Vandvik I.H., Eckblad G. Relationship between pain, disease severity and psychosocial function in patients with juvenile chronic arthritis (JCA). Scand. J. Rheumatol 1990, 19:295-302.
338. Walco G.A., Varni J.W., Ilowite N.T. Cognitive-behavioral pain management in children with juvenile rheumatoid arthritis. Pediatrics 1992, 89:1075-1079.
339. Sallfors C., Hallberg L.R., Fasth A. Gender and age differences in pain, coping and health status among children with chronic arthritis. Clin. Exp. Rheumatol 2003, 21:785-793.
340. Malleson P.N., Oen K., Cabral D.A., et al. Predictors of pain in children with established juvenile rheumatoid arthritis. Arthritis Rheum 2004, 51:222-227.
341. Varni J.W., Thompson K.L., Hanson V. The Varni/Thompson Pediatric Pain Questionnaire. I. Chronic musculoskeletal pain in juvenile rheumatoid arthritis,. Pain 1987, 28:27-38.
342. Lovell D.J., Athreya B., Emery H.M., et al. School attendance and pattern: special services and special needs in pediatric patients with rheumatic diseases. Arthritis Care Res 1990, 3:196.
343. Power T.G., Dahlquist L.M., Thompson S.M., et al. Interactions between children with juvenile rheumatoid arthritis and their mothers. J. Pediatr. Psychol 2003, 28:213-221.
344. Bloom B.J., Tucker L.B., Miller L.C., et al. Bicipital synovial cysts in juvenile rheumatoid arthritis: clinical description and sonographic correlation. J. Rheumatol 1995, 22:1953-1955.
345. Rennebohm R.M., Towbin R.B., Crowe W.E., et al. Popliteal cysts in juvenile rheumatoid arthritis. Am. J. Roentgenol 1983, 140:123-125.
346. Dinham J.M. Popliteal cysts in children: the case against surgery. J. Bone Joint Surg. Br 1975, 57:69-71.
347. Foster H.E., Kay L.J., Friswell M., et al. Musculoskeletal screening examination (pGALS) for school age children based on the adult GALS screen. Arthritis Rheum 2006, 55:709-716.
348. Uziel Y., Rathaus V., Pomeranz A., et al. Torticollis as the sole initial presenting sign of systemic onset juvenile rheumatoid arthritis. J. Rheumatol 1998, 25:166-168.
349. Malleson P., Riding K., Petty R. Stridor due to cricoarytenoid arthritis in pauciarticular onset juvenile rheumatoid arthritis. J. Rheumatol 1986, 13:952-953.
350. Siamopoulou-Mavridou A., Asimakopoulos D., Mavridis A., et al. Middle ear function in patients with juvenile chronic arthritis. Ann. Rheum. Dis 1990, 49:620-623.
351. Wang F.M., Wertenbaker C., Behrens M.M., et al. Acquired Brown's syndrome in children with juvenile rheumatoid arthritis. Ophthalmology 1984, 91:23-26.
352. Moore A.T., Morin J.D. Bilateral acquired inflammatory Brown's syndrome. J. Pediatr. Ophthalmol. Strabismus 1985, 22:26-30.
353. Saha M.T., Verronen P., Laippala P., et al. Growth of prepubertal children with juvenile chronic arthritis. Acta. Paediatr 1999, 88:724-728.
354. Bacon M.C., White P. A new approach to the assessment of growth in JRA,. Arthritis Rheum 1987, 30:S132.
355. Lovell D.J., White P.H. Growth and nutrition in juvenile rheumatoid arthritis. Paediatric Rheumatology Update 1990, Oxford University Press, Oxford. P. Woo, P.H. White, B.M. Ansell (Eds.).
356. Garcia-Consuegra M.J., Merino M.R., Lama M.R., et al. Growth in children with juvenile idiopathic arthritis. Ann. Pediatr. (Barc.) 2003, 58:529-537.
357. Wong S.C., MacRae V.E., Gracie J.A., et al. Inflammatory cytokines in juvenile idiopathic arthritis: effects on physical growth and the insulin-like growth factor axis. Growth. Horm. IgF. Res 2008, 18:369-378.
358. Davies U.M., Jones J., Reeve J., et al. Juvenile rheumatoid arthritis: effects of disease activity and recombinant human growth hormone on insulin-like growth factor 1, insulin-like growth factor binding proteins 1 and 3, and osteocalcin. Arthritis Rheum 1997, 40:332-340.
359. De Benedetti F., Alonzi T., Moretta A., et al. Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation,. J. Clin. Invest 1997, 99:643-650.
360. Sherry D.D., Stein L.D., Reed A.M., et al. Prevention of leg length discrepancy in young children with pauciarticular juvenile rheumatoid arthritis by treatment with intraarticular steroids. Arthritis Rheum 1999, 42:2330-2334.
361. Olson L., Eckerdal O., Hallonsten A.L., et al. Craniomandibular function in juvenile chronic arthritis: a clinical and radiographic study. Swed. Dent. J 1991, 15:71-83.
362. Ronchezel M.V., Hilario M.O., Goldenberg J., et al. Temporomandibular joint and mandibular growth alterations in patients with juvenile rheumatoid arthritis. J. Rheumatol 1995, 22:1956-1961.
363. Avrahami E., Segal R., Solomon A., et al. Direct coronal high resolution computed tomography of the temporomandibular joints in patients with rheumatoid arthritis. J. Rheumatol 1989, 16:298-301.
364. Walton A.G., Welbury R.R., Foster H.E., et al. Juvenile chronic arthritis: a dental review. Oral. Dis 1999, 5:68-75.
365. Rusconi R., Corona F., Grassi A., et al. Age at menarche in juvenile rheumatoid arthritis. J. Pediatr. Endocrinol. Metab 2003, 16(suppl 2):285-288.
366. Hillman L., Cassidy J.T., Johnson L., et al. Vitamin D metabolism and bone mineralization in children with juvenile rheumatoid arthritis. J. Pediatr 1994, 124:910-916.
367. Cassidy J.T., Langman C.B., Allen S.H., et al. Bone mineral metabolism in children with juvenile rheumatoid arthritis. Pediatr. Clin. North Am 1995, 42:1017-1033.
368. Cassidy J.T., Hillman L.S. Abnormalities in skeletal growth in children with juvenile rheumatoid arthritis. Rheum. Dis. Clin. North Am 1997, 23:499-522.
369. Henderson C.J., Cawkwell G.D., Specker B.L., et al. Predictors of total body bone mineral density in non-corticosteroid-treated prepubertal children with juvenile rheumatoid arthritis. Arthritis Rheum 1997, 40:1967-1975.
370. Kotaniemi A., Savolainen A., Kroger H., et al. Development of bone mineral density at the lumbar spine and femoral neck in juvenile chronic arthritis-a prospective one year followup study. J. Rheumatol 1998, 25:2450-2455.
371. Falcini F., Ermini M., Bagnoli F. Bone turnover is reduced in children with juvenile rheumatoid arthritis. J. Endocrinol. Invest 1998, 21:31-36.
372. Cimaz R., Biggioggero M. Osteoporosis. Curr. Rheumatol. Rep 2001, 3:365-370.
373. French A.R., Mason T., Nelson A.M., et al. Osteopenia in adults with a history of juvenile rheumatoid arthritis: a population based study. J. Rheumatol 2002, 29:1065-1070.
374. Roth J., Bechtold S., Borte G., et al. Osteoporosis in juvenile idiopathic arthritis-a practical approach to diagnosis and therapy. Eur. J. Pediatr 2007, 166:775-784.
375. Zak M., Hassager C., Lovell D.J., et al. Assessment of bone mineral density in adults with a history of juvenile chronic arthritis: a cross-sectional long-term follow-up study. Arthritis Rheum 1999, 42:790-798.
376. Henderson C.J., Specker B.L., Sierra R.I., et al. Total-body bone mineral content in non-corticosteroid-treated postpubertal females with juvenile rheumatoid arthritis: frequency of osteopenia and contributing factors. Arthritis Rheum 2000, 43:531-540.
377. Haugen M., Lien G., Flato B., et al. Young adults with juvenile arthritis in remission attain normal peak bone mass at the lumbar spine and forearm. Arthritis Rheum 2000, 43:1504-1510.
378. Masi L., Cimaz R., Simonini G., et al. Association of low bone mass with vitamin D receptor gene and calcitonin receptor gene polymorphisms in juvenile idiopathic arthritis. J. Rheumatol 2002, 29:2225-2231.
379. Lelieveld O.T., Armbrust W., Van Leeuwen M.A., et al. Physical activity in adolescents with juvenile idiopathic arthritis. Arthritis Rheum 2008, 59:1379-1384.
380. Takken T., Hemel A., van der Net J.J., et al. Aerobic fitness in children with juvenile idiopathic arthritis: a systematic review. J. Rheumatol 2002, 29:2643-2647.
381. Gedalia A., Gewanter H., Baum J. Dark skin discoloration of finger joints in juvenile arthritis. J. Rheumatol 1989, 16:797-799.
382. Athreya B.H., Ostrov B.E., Eichenfield A.H., et al. Lymphedema associated with juvenile rheumatoid arthritis. J. Rheumatol 1989, 16:1338-1340.
383. Bardare M., Falcini F., Hertzberger-ten Cate R., et al. Idiopathic limb edema in children with chronic arthritis: a multicenter report of 12 cases. J. Rheumatol 1997, 24:384-388.
384. Schmit P., Prieur A.M., Brunelle F. Juvenile rheumatoid arthritis and lymphoedema: lymphangiographic aspects. Pediatr. Radiol 1999, 29:364-366.
385. Ellsworth J.E., Cassidy J.T., Ragsdale C.G., et al. Mucha-Habermann disease in children-the association with rheumatic diseases. J. Rheumatol 1982, 9:319-324.
386. Person D.A., He X.H., Brewer E.J. Vasculitis in children with juvenile rheumatoid arthritis. J. Rheumatol 1986, 13:219.
387. Vostrejs M., Hollister J.R. Muscle atrophy and leg length discrepancies in pauciarticular juvenile rheumatoid arthritis. Am. J. Dis. Child 1988, 142:343-345.
388. Kruithof E., Van den Bossche V., De Ryke L., et al. Distinct synovial histopathologic characteristics of juvenile onset spondyloarthritis and other forms of juvenile idiopathic arthritis. Arthritis Rheum 2006, 54:2594-2604.
389. Roy C.N., Weinstein D.A., Andrews N.C. 2002 E. Mead Johnson Award for Research in Pediatrics Lecture: The molecular biology of the anemia of chronic disease: a hypothesis. Pediatr. Res 2003, 53:507-512.
390. Giannini E.H., Brewer E.J. Poor correlation between the erythrocyte sedimentation rate and clinical activity in juvenile rheumatoid arthritis. Clin. Rheumatol 1987, 6:197-201.
391. Jarvis J.N., Taylor H., Iobidze M., et al. Complement activation and immune complexes in children with polyarticular juvenile rheumatoid arthritis: a longitudinal study. J. Rheumatol 1994, 21:1124-1127.
392. Bhardwaj A., Aggarwal A., Agarwal V., et al. Role of IgM & IgA rheumatoid factors in complement activation in patients with juvenile rheumatoid arthritis. Indian. J. Med. Res 2000, 111:103-109.
393. Cassidy J.T., Petty R.E., Sullivan D.B. Abnormalities in the distribution of serum immunoglobulin concentrations in juvenile rheumatoid arthritis. J. Clin. Invest 1973, 52:1931-1936.
394. Gutowska-Grzegorczyk G., Baum J. Serum immunoglobulin and complement interrelationships in juvenile rheumatoid arthritis. J. Rheumatol 1977, 4:179-185.
395. Roberts-Thomson P.J., Shepherd K., Southwood T.R., et al. Low molecular weight IgM in juvenile chronic arthritis. Arch. Dis. Child 1988, 63:1453-1456.
396. Eichenfield A.H., Athreya B.H., Doughty R.A., et al. Utility of rheumatoid factor in the diagnosis of juvenile rheumatoid arthritis. Pediatrics 1986, 78:480-484.
397. Brunner J.K., Sitzmann F.C. The diagnostic value of anti cyclic citrullinated peptide (CCP) antibodies in children with juvenile idiopathic arthritis,. Clin. Exp. Rheumatol 2006, 24:449-451.
398. Moore T., Dorner R.W., Zuckner J. Hidden rheumatoid factor in seronegative juvenile rheumatoid arthritis. Ann. Rheum. Dis 1974, 33:255-257.
399. Emancipator K., Moore T.L., Dorner R.W., et al. Hidden and classical 19S IgM rheumatoid factor in a juvenile rheumatoid arthritis patient. J. Rheumatol 1985, 12:372-375.
400. Petty R.E., Cassidy J.T., Sullivan D.B. Clinical correlates of antinuclear antibodies in juvenile rheumatoid arthritis. J. Pediatr 1973, 83:386-389.
401. Schaller J.G., Johnson G.D., Holborow E.J., et al. The association of antinuclear antibodies with the chronic iridocyclitis of juvenile rheumatoid arthritis (Still's disease). Arthritis Rheum 1974, 17:409-416.
402. Allen R.C., Dewez P., Stuart L., et al. Antinuclear antibodies using HEp-2 cells in normal children and in children with common infections. J. Paediatr. Child Health 1991, 27:39-42.
403. Cabral D.A., Petty R.E., Fung M., et al. Persistent antinuclear antibodies in children without identifiable inflammatory rheumatic or autoimmune disease. Pediatrics 1992, 89:441-444.
404. Deane P.M., Liard G., Siegel D.M., et al. The outcome of children referred to a pediatric rheumatology clinic with a positive antinuclear antibody test but without an autoimmune disease. Pediatrics 1995, 95:892-895.
405. Ilowite N.T., Samuel P., Beseler L., et al. Dyslipoproteinemia in juvenile rheumatoid arthritis. J. Pediatr 1989, 114:823-826.
406. Bakkaloglu A., Kirel B., Ozen S., et al. Plasma lipids and lipoproteins in juvenile chronic arthritis. Clin. Rheumatol 1996, 15:341-345.
407. Tselepis A.D., Elisaf M., Besis S., et al. Association of the inflammatory state in active juvenile rheumatoid arthritis with hypo-high-density lipoproteinemia and reduced lipoprotein-associated platelet-activating factor acetylhydrolase activity. Arthritis Rheum 1999, 42:373-383.
408. Gonçalves M., D'Almeida V., Guerra-Shinohara E.M., et al. Homocysteine and lipid profile in children with juvenile idiopathic arthritis. Pediatr. Rheumatol. Online J 2007, 5:2.
409. Mollnes T.E., Paus A. Complement activation in synovial fluid and tissue from patients with juvenile rheumatoid arthritis. Arthritis Rheum 1986, 29:1359-1364.
410. Rynes R.I., Ruddy S., Spragg J., et al. Intraarticular activation of the complement system in patients with juvenile rheumatoid arthritis. Arthritis Rheum 1976, 19:161-168.
411. Miller J.J., Olds L.C., Huene D.B. Complement activation products and factors influencing phagocyte migration in synovial fluids from children with chronic arthritis. Clin. Exp. Rheumatol 1986, 4:53-56.
412. Rapoff M.A., Belmont J., Lindsley C., et al. Prevention of nonadherence to nonsteroidal anti-inflammatory medications for newly diagnosed patients with juvenile rheumatoid arthritis. Health Psychol 2002, 21:620-623.
413. Tucker L.B., Cabral D.A. Transition of the adolescent patient with rheumatic disease: issues to consider. Ped. Clin. North Am 2005, 52:641-652.
414. Ruperto N., Levinson J.E., Ravelli A., et al. Long-term health outcomes and quality of life in American and Italian inception cohorts of patients with juvenile rheumatoid arthritis. I. Outcome status. J. Rheumatol 1997, 24:945-951.
415. Giannini E.H., Ruperto N., Ravelli A., et al. Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum 1997, 40:1202-1209.
416. Ruperto N., Ravelli A., Falcini F., et al. Responsiveness of outcome measures in juvenile chronic arthritis. Italian Pediatric Rheumatology Study Group. Rheumatology (Oxf.) 1999, 28:176-180.
417. Brunner H.I., Lovell D.J., Finck B.K., et al. Preliminary definition of disease flare in juvenile rheumatoid arthritis. J. Rheumatol 2002, 29:1058-1064.
418. Yazici Y., Erkan D., Paget S.A. Monitoring by rheumatologists for methotrexate-, etanercept-, infliximab-, and anakinra-associated adverse events. Arthritis Rheum 2003, 48:2769-2772.
419. Helliwell P.S., Ibrahim G. Ethnic differences in responses to disease modifying drugs. Rheumatology (Oxf.) 2003, 42:1197-1201.
420. Horstman J. The Arthritis Foundation guide to alternative therapies 1999, Arthritis Foundation, Atlanta.
421. Cimaz R., Corona F., Scarazatti M., et al. Methotrexate treatment every other week in patients with juvenile chronic arthritis. Br. J. Rheumatol 1996, 35:1030-1031.
422. Knops N., Wulffraat N., Lodder S., et al. Resting energy expenditure and nutritional status in children with juvenile rheumatoid arthritis. J. Rheumatol 1999, 26:2039-2043.
423. Martini A., Ravelli A., Di Fuccia G., et al. Intravenous iron therapy for severe anaemia in systemic-onset juvenile chronic arthritis. Lancet 1994, 344:1052-1054.
424. Henderson C.J., Lovell D.J. Nutritional aspects of juvenile rheumatoid arthritis. Rheum. Dis. Clin. North Am 1991, 17:403-413.
425. Hafner R., Truckenbrodt H., Spamer M. Rehabilitation in children with juvenile chronic arthritis. Baillieres. Clin. Rheumatol 1998, 12:329-361.
426. Kuchta G, Davidson I: Occupational and Physical Therapy for Children with Rheumatic Diseases, Radcliffe, Oxford (2009).
427. Pahle J.A. Orthopaedic management of juvenile chronic arthritis (JCA). Z. Rheumatol 1996, 55:376-387.
428. Swann M. The surgery of juvenile chronic arthritis. an overview. Clin. Orthop 1990, 70-75.
429. Hamalainen M. Surgical treatment of juvenile rheumatoid arthritis. Clin. Exp. Rheumatol 1994, 12(suppl. 10):S107-S112.
430. Price C.T. Are we there yet? Management of limb-length inequality. J. Pediatr. Orthop 1996, 16:141-143. 129.
431. Granberry W.M. Synovectomy in juvenile rheumatoid arthritis. Arthritis Rheum 1977, 20:561-564.
432. Jacobsen S.T., Levinson J.E., Crawford A.H. Late results of synovectomy in juvenile rheumatoid arthritis. J. Bone Joint Surg. Am 1985, 67:8-15.
433. Rydholm U., Elborgh R., Ranstam J., et al. Synovectomy of the knee in juvenile chronic arthritis. a retrospective, consecutive follow-up study. J. Bone Joint Surg. Br 1986, 68:223-228.
434. Kvien T.K., Pahle J.A., Hoyeraal H.M., et al. Comparison of synovectomy and no synovectomy in patients with juvenile rheumatoid arthritis: a 24-month controlled study. Scand. J. Rheumatol 1987, 16:81-91.
435. Hafner R., Pieper M. Arthroscopic synovectomy of the knee joint in chronic juvenile arthritis. Z. Rheumatol 1995, 54:165-170.
436. Carl H.-D., Schraml A., Swoboda B., et al. Synovectomy of the hip in patients with juvenile rheumatoid arthritis. J. Bone Joint Surg 2007, 89:1986-1992.
437. Dell'Era L., Facchini R., Corona F. Knee synovectomy in children with juvenile idiopathic arthritis. J. Ped. Ortho. B 2008, 17:128-130.
438. Chmell M.J., Scott R.D., Thomas W.H., et al. Total hip arthroplasty with cement for juvenile rheumatoid arthritis: results at a minimum of ten years in patients less than thirty years old. J. Bone Joint Surg. Am 1997, 79:44-52.
439. Parvizi J., Lajam C.M., Trousdale R.T., et al. Total knee arthroplasty in young patients with juvenile rheumatoid arthritis. J. Bone Joint Surg Am 2003, 85:1090-1094.
440. Rapoff M.A., Lindsley C.B., Christophersen E.R. Parent perceptions of problems experienced by their children in complying with treatments for juvenile rheumatoid arthritis. Arch. Phys. Med. Rehabil 1985, 66:427-429.
441. Kroll T., Barlow J.H., Shaw K. Treatment adherence in juvenile rheumatoid arthritis-a review. Scand. J. Rheumatol 1999, 28:10-18.
442. Frank R.G., Hagglund K.J., Schopp L.H., et al. Disease and family contributors to adaptation in juvenile rheumatoid arthritis and juvenile diabetes. Arthritis Care Res 1998, 11:166-176.
443. Frank R.G., Thayer J.F., Hagglund K.J., et al. Trajectories of adaptation in pediatric chronic illness: the importance of the individual. J. Consult. Clin. Psychol 1998, 66:521-532.
444. Pless I.B., Satterwhite B., Van Vechten D. Division, duplication and neglect: patterns of care for children with chronic disorders. Child Care Health Dev 1978, 4:9-19.
445. Dempster H., Porepa M., Young N., et al. The clinical meaning of functional outcome scores in children with juvenile arthritis,. Arthritis Rheum 2001, 44:1768-1774.
446. Michels H., Hafner R., Morhart R., et al. Five year follow-up of a prospective cohort of juvenile chronic arthritis with recent onset. Clin. Rheumatol 1987, 6(suppl. 2):87-92.
447. Fantini F., Gerloni V., Gattinara M., et al. Remission in juvenile chronic arthritis: a cohort study of 683 consecutive cases with a mean 10 year followup. J. Rheumatol 2003, 30:579-584.
448. Hill R.H., Herstein A., Walters K. Juvenile rheumatoid arthritis: follow-up into adulthood-medical, sexual and social status. Can. Med. Assoc. J 1976, 114:790-796.
449. FitzGerald O., Bresnihan B. Juvenile chronic arthritis: spectrum of disease in an adult rheumatology department. Ir. J. Med. Sci 1986, 155:266-271.
450. Zak M., Pedersen F.K. Juvenile chronic arthritis into adulthood: a long-term follow-up study. Rheumatology (Oxf.) 2000, 39:198-204.
451. Oen K., Malleson P.N., Cabral D.A., et al. Early predictors of longterm outcome in patients with juvenile rheumatoid arthritis: subset-specific correlations. J. Rheumatol 2003, 30:585-593.
452. Guillaume S., Prieur A.M., Coste J., et al. Long-term outcome and prognosis in oligoarticular-onset juvenile idiopathic arthritis. Arthritis Rheum 2000, 43:1858-1865.
453. Lomater C., Gerloni V., Gattinara M., et al. Systemic onset juvenile idiopathic arthritis: a retrospective study of 80 consecutive patients followed for 10 years. J. Rheumatol 2000, 27:491-496.
454. Spiegel L.R., Schneider R., Lang B.A., et al. Early predictors of poor functional outcome in systemic-onset juvenile rheumatoid arthritis: a multicenter cohort study. Arthritis Rheum 2000, 43:2402-2409.
455. Aggarwal A., Agarwal V., Danda D., et al. Outcome in juvenile rheumatoid arthritis in India. Indian. Pediatr 2004, 41:180-184.
456. Hafner R., Truckenbrodt H. Course and prognosis of systemic juvenile chronic arthritis-retrospective study of 187 patients. Klin. Padiatr 1986, 198:401-407.
457. Schuchmann L., Michels H., Morhart R., et al. Prospective observation study on the clinical course of chronic juvenile arthritis (JCA). Monatsschr. Kinderheilkd 1986, 134:164-167.
458. Packham J.C., Hall M.A. Long-term follow-up of 246 adults with juvenile idiopathic arthritis: functional outcome. Rheumatology (Oxf.) 2002, 41:1428-1435.
459. Packham J.C., Hall M.A., Pimm T.J. Long-term follow-up of 246 adults with juvenile idiopathic arthritis: predictive factors for mood and pain. Rheumatology (Oxf.) 2002, 41:1444-1449.
460. Packham J.C., Hall M.A. Long-term follow-up of 246 adults with juvenile idiopathic arthritis: social function, relationships and sexual activity. Rheumatology (Oxf.) 2002, 41:1440-1443.
461. Packham J.C., Hall M.A. Long-term follow-up of 246 adults with juvenile idiopathic arthritis: education and employment. Rheumatology (Oxf.) 2002, 41:1436-1439.
462. Minden K., Niewerth M., Listing J., et al. Long-term outcome in patients with juvenile idiopathic arthritis. Arthritis Rheum 2002, 46:2392-2401.
463. Oen K. Long-term outcomes and predictors of outcomes for patients with juvenile idiopathic arthritis. Best Pract. Res. Clin. Rheumatol 2002, 16:347-360.
464. Foster H.E., Marshall N., Myers A., et al. Outcome in adults with juvenile idiopathic arthritis: a quality of life study. Arthritis Rheum 2003, 48:767-775.
465. Wallace C.A., Levinson J.E. Juvenile rheumatoid arthritis: outcome and treatment for the 1990s. Rheum. Dis. Clin. North Am 1991, 17:891-905.
466. Ravelli A. Toward an understanding of the long-term outcome of juvenile idiopathic arthritis. Clin. Exp. Rheumatol 2004, 22:271-275.
467. Ruperto N., Ravelli A., Levinson J.E., et al. Long-term health outcomes and quality of life in American and Italian inception cohorts of patients with juvenile rheumatoid arthritis. II. Early predictors of outcome. J. Rheumatol 1997, 24:952-958.
468. Bowyer S.L., Roettcher P.A., Higgins G.C., et al. Health status of patients with juvenile rheumatoid arthritis at 1 and 5 years after diagnosis. J. Rheumatol 2003, 30:394-400.
469. Brunner H.I., Giannini E.H. Health-related quality of life in children with rheumatic diseases. Curr. Opin. Rheumatol 2003, 15:602-612.
470. Selvaag A.M., Flato B., Lien G., et al. Measuring health status in early juvenile idiopathic arthritis: determinants and responsiveness of the child health questionnaire. J. Rheumatol 2003, 30:1602-1610.
471. Oen K., Malleson P.N., Cabral D.A., et al. Disease course and outcome of juvenile rheumatoid arthritis in a multicenter cohort. J. Rheumatol 2002, 29:1989-1999.
472. Oen K., Reed M., Malleson P.N., et al. Radiologic outcome and its relationship to functional disability in juvenile rheumatoid arthritis. J. Rheumatol 2003, 30:832-840.
473. LeBovidge J.S., Lavigne J.V., Donenberg G.R., et al. Psychological adjustment of children and adolescents with chronic arthritis: a meta-analytic review. J. Pediatr. Psychol 2003, 28:29-39.
474. Hutchison T. The classification of disability,. Arch. Dis. Child 1995, 73:91-93.
475. Peterson L.S., Mason T., Nelson A.M., et al. Psychosocial outcomes and health status of adults who have had juvenile rheumatoid arthritis: a controlled, population-based study. Arthritis Rheum 1997, 40:2235-2240.
476. Flato B., Lien G., Smerdel A., et al. Prognostic factors in juvenile rheumatoid arthritis: a case-control study revealing early predictors and outcome after 14.9 years. J. Rheumatol 2003, 30:386-393.
477. Flato B., Aasland A., Vinje O., et al. Outcome and predictive factors in juvenile rheumatoid arthritis and juvenile spondyloarthropathy. J. Rheumatol 1998, 25:366-375.
478. Aasland A., Flato B., Vandvik I.H. Psychosocial outcome in juvenile chronic arthritis: a nine-year follow-up. Clin. Exp. Rheumatol 1997, 15:561-568.
479. Flato B., Aasland A., Vinje O., et al. Outcome and predictive factors in juvenile rheumatoid arthritis and juvenile spondyloarthropathy. J. Rheumatol 1998, 25:366-375.
480. Carter B.D., Kronenberger W.G., Edwards J.F., et al. Psychological symptoms in chronic fatigue and juvenile rheumatoid arthritis. Pediatrics 1999, 103:975-979.
481. Huygen A.C., Kuis W., Sinnema G. Psychological, behavioural, and social adjustment in children and adolescents with juvenile chronic arthritis. Ann. Rheum. Dis 2000, 59:276-282.
482. Noll R.B., Kozlowski K., Gerhardt C., et al. Social, emotional, and behavioral functioning of children with juvenile rheumatoid arthritis. Arthritis Rheum 2000, 43:1387-1396.
483. von Weiss R.T., Rapoff M.A., Varni J.W., et al. Daily hassles and social support as predictors of adjustment in children with pediatric rheumatic disease. J. Pediatr. Psychol 2002, 27:155-165.
484. Hagglund K.J., Clay D.L., Frank R.G., et al. Assessing anger expression in children and adolescents. J. Pediatr 1994, 19:291-304. Psychol.
485. Press J., Neumann L., Uziel Y., et al. Assessment of quality of life of parents of children with juvenile chronic arthritis. Clin. Rheumatol 2002, 21:280-283.
486. Wagner J.L., Chaney J.M., Hommel K.A., et al. The influence of parental distress on child depressive symptoms in juvenile rheumatic diseases: the moderating effect of illness intrusiveness. J. Pediatr. Psychol 2003, 28:453-462.
487. Gerhardt C.A., Vannatta K., McKellop J.M., et al. Comparing parental distress, family functioning, and the role of social support for caregivers with and without a child with juvenile rheumatoid arthritis. J. Pediatr. Psychol 2003, 28:5-15.
488. Spencer C.H., Fife R.Z., Rabinovich C.E. The school experience of children with arthritis. Coping in the 1990s and transition into adulthood,. Pediatr. Clin. North Am 1995, 42:1285-1298.
489. Chamberlain M.A., Rooney C.M. Young adults with arthritis: meeting their transitional needs. Br. J. Rheumatol 1996, 35:84-90.
490. White P.H. Future expectations: adolescents with rheumatic diseases and their transition into adulthood. Br. J. Rheumatol 1996, 35:80-83.
491. White P.H. Resilience in children with disabilities-transition to adulthood. J. Rheumatol 1996, 23:960-962.
492. White P.H. Success on the road to adulthood. Issues and hurdles for adolescents with disabilities. Rheum. Dis. Clin. North Am 1997, 23:697-707.
493. Baum J., Gutowska G. Death in juvenile rheumatoid arthritis. Arthritis Rheum 1977, 20((suppl):253.
494. Bernstein B. Death in juvenile rheumatoid arthritis. Arthritis Rheum 1977, 20((suppl):256.
495. Thomas E., Symmons D.P., Brewster D.H., et al. National study of cause-specific mortality in rheumatoid arthritis, juvenile chronic arthritis, and other rheumatic conditions: a 20 year followup study. J. Rheumatol 2003, 30:958-965.
496. Schuchmann L., Michels H., Renaud M., et al. Amyloidosis-a dreaded complication of juvenile chronic arthritis (JCA) (author's transl). Klin. Padiatr 1981, 193:67-72.
497. Bywaters E.G.L. Deaths in juvenile chronic polyarthritis. Arthritis Rheum 1977, 20((suppl):256.
498. Arden G.P. Sepsis in juvenile chronic polyarthritis. Surgical Management of Juvenile Chronic Polyarthritis 1978, Academic Press, London. G.P. Arden, B.M. Ansell (Eds.).
499. David J., Vouyiouka O., Ansell B.M., et al. Amyloidosis in juvenile chronic arthritis: a morbidity and mortality study. Clin. Exp. Rheumatol 1993, 11:85-90.
500. Ozdogan H., Kasapcopur O., Dede H., et al. Juvenile chronic arthritis in a Turkish population. Clin. Exp. Rheumatol 1991, 9:431-435.
501. Woo P. Amyloidosis in pediatric rheumatic diseases. J. Rheumatol 1992, 35((suppl):10-16.
502. Gwyther M., Schwarz H., Howard A., et al. C-reactive protein in juvenile chronic arthritis: an indicator of disease activity and possibly amyloidosis. Ann. Rheum. Dis 1982, 41:259-262.
503. Burman S.J., Hall P.J., Bedford P.A., et al. HLA antigen frequencies among patients with juvenile chronic arthritis and amyloidosis: a brief report. Clin. Exp. Rheumatol 1986, 4:261-263.
504. Woo P., O'Brien J., Robson M., et al. A genetic marker for systemic amyloidosis in juvenile arthritis,. Lancet 1987, 2:767-769.
505. Linke R.P., Gartner H.V., Michels H. High-sensitivity diagnosis of AA amyloidosis using Congo red and immunohistochemistry detects missed amyloid deposits. J. Histochem. Cytochem 1995, 43:863-869.
506. Hawkins P.N., Richardson S., Vigushin D.M., et al. Serum amyloid P component scintigraphy and turnover studies for diagnosis and quantitative monitoring of AA amyloidosis in juvenile rheumatoid arthritis. Arthritis Rheum 1993, 36:842-851.
507. Allaire S.H., DeNardo B.S., Szer I.S., et al. The economic impacts of juvenile rheumatoid arthritis,. J. Rheumatol 1992, 19:952-955.
508. Minden K., Niewerth M., Listing J., et al. Burden and cost of illness in children with juvenile idiopathic arthritis. Ann. Rheum. Dis 2004, 63:836-842.
509. Bernatsky S., Duffy C., Malleson P., et al. Economic impact of juvenile idiopathic arthritis. Arthritis Care Res 2007, 57:44-48.
510. Thornton J., Lunt M., Ashcroft D.M., et al. Costing juvenile idiopathic arthritis: examining patient based costs during the first year after diagnosis. Rheumatology (Oxf.) 2008, 47:985-990.